Showing results (421-430 of 2,330) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|November 26, 2021
Safety and Efficacy of the FLECTOR (Diclofenac Epolamine) Topical System in Children with Minor Soft Tissue Injuries: A Phase IV Non-randomized Clinical TrialChristopher A Jones, Fred K Hoehler, Valeria Frangione, et al.
Clinical Drug Investigation|January 12, 2022
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM TrialC Louwrens Braal, Anne Kleijburg, Agnes Jager, et al.
Clinical Drug Investigation|January 19, 2022
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer PatientsVered Fuchs, Waleed Kian, Rachel Lichtenberg, et al.
Clinical Drug Investigation|January 21, 2022
Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic StrokeNobuyuki Sakai, Masataka Takeuchi, Hirotoshi Imamura, et al.
Clinical Drug Investigation|November 16, 2021
An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer PainEiso Hiyama, Shigeki Yamaguchi, Koji Okawa, et al.
Clinical Drug Investigation|December 7, 2021
Application of Multicriteria Decision Analysis to Determine the Value of Prophylaxis Relative to On-Demand Treatment in Hemophilia A and Emicizumab versus Replacement Therapy in the Greek Healthcare SettingGeorge Gourzoulidis, Garyfallia Stefanou, Marina Economou, et al.
Clinical Drug Investigation|November 3, 2022
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy SubjectsMikkel Askjær Agersnap, Kim Sonne, Kim Mark Knudsen, et al.
Clinical Drug Investigation|November 4, 2022
Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability StudiesNicolas Atrux-Tallau, Zulaikha Naimi, Eric-Olivier Jaudinot
Clinical Drug Investigation|October 10, 2022
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 TrialAmy Legg, Niamh Meagher, Sandra A Johnson, et al.
Clinical Drug Investigation|October 31, 2022
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMohamed Abuelazm, Ahmed Ghanem, Ahmed K Awad, et al.
Pageof 233